Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update
- PMID: 18295145
- DOI: 10.1016/j.chc.2007.11.006
Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update
Abstract
Epidemiologic data on attention deficit hyperactivity disorder (ADHD) are essential for planning health services and implementing strategies of detection and early intervention, with possible substantial benefits on public health. This article addresses methodological aspects of prevalence studies, recent findings on the prevalence of ADHD in childhood and adolescence based on a systematic review, current findings on the persistence of the disorder over time and prevalence in adulthood, and factors associated with ADHD. Evidence from the reviewed literature indicates the importance of methodological aspects in the understanding of epidemiologic findings and the necessity of large-scale cross-national studies. Moreover, governments clearly must direct attention to childhood mental disorders to guarantee a healthy future for their countries.
Similar articles
-
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2. Cochrane Database Syst Rev. 2018. PMID: 29744873 Free PMC article.
-
Attention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: Update 2016.Curr Psychiatry Rep. 2017 Jan;19(1):4. doi: 10.1007/s11920-017-0754-1. Curr Psychiatry Rep. 2017. PMID: 28102515 Free PMC article.
-
[Detailed review of epidemiologic studies on adult Attention Deficit/Hyperactivity Disorder (ADHD)].Psychiatr Hung. 2007;22(1):4-19. Psychiatr Hung. 2007. PMID: 17558040 Hungarian.
-
Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review.Eur Child Adolesc Psychiatry. 2017 Sep;26(9):1093-1103. doi: 10.1007/s00787-017-1020-0. Epub 2017 Jul 3. Eur Child Adolesc Psychiatry. 2017. PMID: 28674760 Free PMC article.
-
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2. Cochrane Database Syst Rev. 2022. PMID: 35844168 Free PMC article.
Cited by
-
ADHD prevalence estimates in Italian children and adolescents: a methodological issue.Ital J Pediatr. 2018 Sep 5;44(1):108. doi: 10.1186/s13052-018-0545-2. Ital J Pediatr. 2018. PMID: 30185215 Free PMC article. Review.
-
Emotion regulation mediates the association between ADHD and depressive symptoms in a community sample of youth.J Abnorm Child Psychol. 2014 May;42(4):611-21. doi: 10.1007/s10802-013-9799-8. J Abnorm Child Psychol. 2014. PMID: 24221724 Free PMC article.
-
Challenges and coping mechanisms of parents of children with attention deficit hyperactivity disorder in Addis Ababa, Ethiopia: a qualitative study.BMC Psychol. 2024 Jun 17;12(1):354. doi: 10.1186/s40359-024-01828-0. BMC Psychol. 2024. PMID: 38886856 Free PMC article.
-
Do attention deficit/hyperactivity disorder symptoms exist among Brazilian indigenous children?Dement Neuropsychol. 2009 Jan-Mar;3(1):38-40. doi: 10.1590/S1980-57642009DN30100008. Dement Neuropsychol. 2009. PMID: 29213608 Free PMC article.
-
Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study.BMC Pediatr. 2015 Sep 10;15:118. doi: 10.1186/s12887-015-0435-3. BMC Pediatr. 2015. PMID: 26357902 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical